Kintara Therapeutics Inc (NASDAQ:KTRA) price closed lower on Monday, May 06, dropping -4.16% below its previous close.
A look at the daily price movement shows that the last close reads $0.15. Taking into account the 52-week price action we note that the stock hit a 52-week high of $5.60 and 52-week low of $0.08. The stock added 11.45% on its value in the past month.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give KTRA a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
The overview shows that KTRA’s price is at present 9.10% off the SMA20 and 27.52% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 55.21, with weekly volatility standing at 9.41%. The indicator jumps to 13.86% when calculated based on the past 30 days. Kintara Therapeutics Inc (NASDAQ:KTRA)’s beta value is holding at 0.47, while the average true range (ATR) indicator is currently reading 0.02.
An analysis of the Kintara Therapeutics Inc (NASDAQ:KTRA) stock in terms of its daily trading volume indicates that the 3-month average is 14.49 million.
Current records show that the company has 55.30M in outstanding shares. The insiders’ percentage holdings are 0.19% of outstanding shares while the percentage share held by institutions stands at 0.40%. But the -14.50% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
